During the past decade, Chungnam National University Hospital conducted 182 clinical trials. In the 10-year time frame, 182 clinical trials started and 43 clinical trials were completed, i.e. on average, 23.6% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 30 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chungnam National University Hospital" #1 sponsor was "Seung-Jung Park" with 29 trials, followed by "Asan Medical Center" with 11 trials sponsored, "Chong Kun Dang Pharmaceutical" with 10 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "Janssen Research & Development, LLC" with 10 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chungnam National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 32 trials as a collaborator, "Chungnam National University Hospital" with 8 trials as a collaborator, "Chonnam National University Hospital" with 4 trials as a collaborator, "Korean Cancer Study Group" with 4 trials as a collaborator and "Kyungpook National University Hospital" with 4 trials as a collaborator. Other collaborators include 120 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "Chungnam National University Hospital" are "Coronary Artery Disease" (30 trials), "Healthy" (8 trials), "Heart Failure" (8 trials), "Rheumatoid Arthritis" (7 trials) and "Gastric Cancer" (6 trials). Many other conditions were trialed in "Chungnam National University Hospital" in a lesser frequency.

Most popular intervention types in "Chungnam National University Hospital" are "Drug" (173 trials), "Device" (29 trials), "Biological" (19 trials), "Procedure" (19 trials) and "Other" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Docetaxel" (4 trials), "Empagliflozin" (4 trials), "Oxaliplatin" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Chungnam National University Hospital" are 245 trials for "All" genders, 12 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are 76 active trials in "Chungnam National University Hospital". 1 are not yet recruiting, 46 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 147 completed trials in Chungnam National University Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Chungnam National University Hospital, 26 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 44 trials, and there were also 15 trials that are defined as “Not Applicable".